- Home
- TXG
TXG
10x Genomics Inc.
as 01-17-2025 3:44pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | PLEASANTON |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $23.86 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.95 - $51.22 | Next Earning Date: | 02-13-2025 |
| Revenue: | $629,743,000 | Revenue Growth: | 6.56% |
| Revenue Growth (this year): | -2.18% | Revenue Growth (next year): | 5.57% |
Stock Insider Trading Activity of 10x Genomics Inc. (TXG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | TXG | See Remarks | Nov 22 '24 | Sell | $13.69 | 5,807 | $79,485.05 | 339,897 | |
| Saxonov Serge | TXG | Chief Executive Officer | Nov 21 '24 | Sell | $13.69 | 6,693 | $91,612.45 | 872,574 |
Latest 10x Genomics Inc. News
TXG Breaking Stock News: Dive into TXG Ticker-Specific Updates for Smart Investing
The Wall Street Journal
10 days ago
Colorado’s Most Expensive Home for Sale Is Listing for $78 Million
PR Newswire
16 days ago
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medical Device Network
19 days ago
Bruker seeks to pause injunction of GeoMx in the US after court ruling
MT Newswires
25 days ago
Update: 10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US
Motley Fool
25 days ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
MT Newswires
a month ago
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US
PR Newswire
a month ago
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
Barrons.com
2 months ago
If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Compare TXG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TXG 10x Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.